NewAmsterdam Pharma Co N.V. SEC filings NAMSW
NewAmsterdam Pharma Co N.V. has 415 filings in SEC EDGAR's recent list, going back to Aug 4, 2022. Its latest annual report, Form ARS, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K | Current report | Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Other events
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 14, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 15, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 13, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Restatement
|
Oct 18, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 29, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 18, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 1, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 15, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2023 | Nov 13, 2023 |
| 6-K | Current report (foreign issuer) | Oct 23, 2023 | Oct 23, 2023 |
| 6-K | Current report (foreign issuer) | Sep 25, 2023 | Sep 25, 2023 |
| 6-K | Current report (foreign issuer) | Sep 21, 2023 | Sep 21, 2023 |
| 6-K | Current report (foreign issuer) | Aug 28, 2023 | Aug 28, 2023 |
| 6-K | Current report (foreign issuer) | Aug 14, 2023 | Aug 14, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Aug 7, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 26, 2023 | Jul 26, 2023 |
| 6-K | Current report (foreign issuer) | Jun 21, 2023 | Jun 21, 2023 |
| 6-K | Current report (foreign issuer) | Jun 12, 2023 | Jun 9, 2023 |
| 6-K | Current report (foreign issuer) | Jun 5, 2023 | Jun 5, 2023 |
| 6-K | Current report (foreign issuer) | May 31, 2023 | May 31, 2023 |
| 6-K | Current report (foreign issuer) | May 23, 2023 | May 23, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | May 8, 2023 |
| 6-K | Current report (foreign issuer) | Apr 24, 2023 | Apr 24, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 6-K | Current report (foreign issuer) | Mar 31, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 7, 2023 | Mar 7, 2023 |
| 6-K | Current report (foreign issuer) | Mar 3, 2023 | Mar 3, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Feb 6, 2023 | Feb 6, 2023 |
| 6-K | Current report (foreign issuer) | Jan 17, 2023 | Jan 17, 2023 |
| 6-K | Current report (foreign issuer) | Jan 11, 2023 | Jan 11, 2023 |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Dec 19, 2022 | Dec 19, 2022 |
| 6-K | Current report (foreign issuer) | Nov 23, 2022 | Nov 23, 2022 |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NAMS (Nasdaq), NAMSW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Narrden, Netherlands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1936258
- Former names
- NewAmsterdam Pharma Co B.V. (until Nov 22, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.